TranspireBio CEO Presents Industry Perspective on FDA's Updated Bioequivalence Framework at FDA/CRCG Workshop
SUNRISE, Fla., Oct. 15, 2026 /PRNewswire/ -- TranspireBio Holdings Inc. (TranspireBio, or the Company), an integrated clinical-stage biopharmaceutical company advancing inhaled therapeutics for respiratory and systemic diseases, today announced that Xian-Ming Zeng, Ph.D., Chief Executive...